Product Information
MELOXICAM 15 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0188 per EA under NDC 69097015907. Its NADAC has been published 596 times since Jan 28, 2015.
Strength
15 mg/1
Manufacturer
Cipla USA Inc.NDC
69097015907
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MELOXICAMApproval Type
Generic (ANDA)
FDA Application
ANDA077929On Market Since
7/19/2006
Pharmacological Classes
Price Statistics
The NADAC for MELOXICAM 15 MG TABLET has been published 596 times since Jan 28, 2015, and over the history we have for it it has declined 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0188 per EA |
|---|---|
| All-time high | $0.0285 (Jun 10, 2015) |
| All-time low | $0.0173 (Nov 20, 2024) |
| 52-week high | $0.0202 |
| 52-week low | $0.0188 |
| Median price | $0.0214 |
| Average price | $0.0218 |
| Largest weekly change | -17.1% (Nov 20, 2024) |
| Weeks tracked | 596 |
| Tracking since | Jan 28, 2015 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MELOXICAM 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MELOXICAM 15 MG TABLET, manufactured by Cipla USA Inc., is $0.0188 per EA (NDC 69097015907), effective Jun 24, 2026.
How has the price of MELOXICAM 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for MELOXICAM 15 MG TABLET has declined 29.0%. It has been tracked across 596 weekly CMS publications since Jan 28, 2015.
What are the highest and lowest recorded NADAC prices for MELOXICAM 15 MG TABLET?
Since Jan 28, 2015, the NADAC for MELOXICAM 15 MG TABLET has ranged from a low of $0.0173 (Nov 20, 2024) to a high of $0.0285 (Jun 10, 2015), with a median of $0.0214 per EA.
Are there cheaper alternatives to MELOXICAM 15 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as MELOXICAM 15 MG TABLET, but none are currently priced below it.
Who manufactures MELOXICAM 15 MG TABLET?
MELOXICAM 15 MG TABLET (NDC 69097015907) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification